Soleno Therapeutics to Participate in Upcoming November Conferences
Provided By GlobeNewswire
Last update: Oct 28, 2025
REDWOOD CITY, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that it will participate in the following investor conferences in November:
Read more at globenewswire.com
